Operating margin moved 116 bp higher
Operating margin changed +116 basis points from the comparable as-filed period.
-1.39%→-0.23%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KVHI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 518 bp lower
Working capital / assets changed -518 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
72.29%→67.10%4 prior comparisons
Operating cash flow / net income increased 110.2%
Operating cash flow / net income changed +110.2% from the comparable as-filed period.
5.48→11.520 prior comparisons
Operating cash-flow margin moved 1358 bp lower
Operating cash-flow margin changed -1358 basis points from the comparable as-filed period.
19.14%→5.57%3 prior comparisons
Receivables / revenue moved 1022 bp lower
Receivables / revenue changed -1022 basis points from the comparable as-filed period.
95.22%→85.00%3 prior comparisons
Current ratio decreased 24.7%
Current ratio changed -24.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
9.39→7.074 prior comparisons
Trade receivables increased 13.1%
Trade receivables changed +13.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$25.4M→$28.7M4 prior comparisons
Working capital decreased 7.8%
Working capital changed -7.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$109.9M→$101.3M4 prior comparisons
Research & development decreased 12.1%
Research & development changed -12.1% from the comparable as-filed period.
$916,000→$805,0003 prior comparisons
Cash & equivalents increased 3.2%
Cash & equivalents changed +3.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$55.9M→$57.7M4 prior comparisons
SBC / revenue moved 41 bp lower
SBC / revenue changed -41 basis points from the comparable as-filed period.
1.63%→1.22%3 prior comparisons
R&D / revenue moved 105 bp lower
R&D / revenue changed -105 basis points from the comparable as-filed period.
3.44%→2.39%3 prior comparisons
Stock-based compensation decreased 5.3%
Stock-based compensation changed -5.3% from the comparable as-filed period.
$434,000→$411,0003 prior comparisons
Total assets decreased 0.7%
Total assets changed -0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$152.0M→$151.0M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.